What is CERS stock price today?

Visit our real-time dashboard for the current CERS stock price and live market data.

Is CERS stock going up or down today?

CERS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CERS stock now?

The decision to buy CERS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CERS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CERS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CERS stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CERS is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CERS's P/E ratio?

P/E ratio data for CERS will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CERS's market cap?

CERS (Cerus Corporation) has a market capitalization of $0.29 billion, making it a small-cap stock.

What is CERS's price to book ratio?

Price-to-book ratio for CERS is available on our dashboard along with other valuation metrics.

Does CERS pay dividends?

CERS does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CERS's dividend yield?

CERS does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CERS stock a good long-term investment?

CERS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CERS's revenue growth rate?

Revenue growth data for CERS is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CERS are available on our dashboard with complete income statement analysis.

What are the risks of investing in CERS?

Key risks for CERS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CERS compare to its competitors?

Compare CERS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CERS's performance and positioning.

What is CERS's stock price target for 2026?

Visit our prediction page for AI-powered price targets for CERS with bull, base, and bear case scenarios.

What do analysts say about CERS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CERS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CERS's next earnings report?

CERS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CERS - Cerus Corporation

NYSE * Healthcare * Medical Devices

$0.00

+$0.00 (+0.00%)

About Cerus Corporation

Cerus Corporation (CERS) common stock

Price Chart

Loading chart...

CERS Key Statistics

Market Cap

$294.39M

How CERS Compares to Peers

CERS is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CERS(This stock)	$294.39M	N/A	0%	0.0%	-
ABTAbbott Laboratories	$154.15B	24.8	0%	0.0%	vs ABT
MDTMedtronic PLC	$100.08B	20.9	0%	0.0%	vs MDT
SYKStryker Corporation	$115.45B	34.9	0%	0.0%	vs SYK
BSXBoston Scientific	$71.81B	20.2	0%	0.0%	vs BSX
ISRGIntuitive Surgical	$195.15B	80.0	0%	0.0%	vs ISRG

Data Updated: July 18, 2026 at 8:06 PM EDT

Ready to invest in CERS?

Commission-free trading available. Affiliate links.

CERS Lician Score

5% confidence

4.0/10

Neutral

CERS has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates CERSacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

CERS Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for CERS

Dashboard

Enter a ticker to analyze